His method of locating genes in human DNA allowed researchers to find disease-causing genes, and later to map the entire, ...

A new study has for the first time elucidated the gut-liver immune regulatory axis jointly maintained by intestinal commensal bacteria and the intestinal endocrine system, and uncovered the ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

ARK Innovation ETF remains a 'Sell' as it underperforms the S&P 500, down over 6% YTD versus S&P's ~2%. Click here to read ...

The announcement that the UK and the EU are moving towards a new Sanitary and Phytosanitary (SPS) agreement represents, in Professor Chris Elliott’s opinion, one of the most significant developments ...

The trajectory of base editing has been remarkable, progressing from the laboratory to patient care, treating debilitating or ...

Demeetra AgBio, Inc. (hereafter "Demeetra") today announced that the renewal of the research license agreement for the piggyBac(R) transposase technology, a widely used platform for genetic ...

Blindness and deafness in some infants and sickle cell are among the conditions cured in recent gene therapy trials.

When his beloved dog was given months to live, an Australian man harnessed the power of machine learning and mRNA technology ...

I'd like to thank you for taking time to join us for Cibus' Fourth Quarter 2025 Financial Results and Business ...

Editas Medicine is a clinical-stage biotech. Pre-commercial drugmakers carry higher-than-average risk, as they routinely encounter significant clinical or regulatory roadblocks that sink their stock ...